Variant report

Variant	nsv511347
Chromosome Location	chr6:29942126-29942857
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:9)
CpG islands
(count:183)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:9 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	E2F6	chr6:29942686-29943660	H1-hESC	embryonic stem cell:	n/a	n/a
2	POLR2A	chr6:29942588-29942676	K562	blood:	n/a	n/a
3	POLR2A	chr6:29942628-29942801	HepG2	liver:	n/a	n/a
4	POLR2A	chr6:29942266-29942585	K562	blood:	n/a	n/a
5	POLR2A	chr6:29936914-29943239	K562	blood:	n/a	n/a
6	SIN3A	chr6:29942645-29943161	H1-hESC	embryonic stem cell:	n/a	n/a
7	TBP	chr6:29942741-29943001	H1-hESC	embryonic stem cell:	n/a	n/a
8	ZNF143	chr6:29942770-29942853	K562	blood:	n/a	chr6:29942794-29942813
9	ZNF143	chr6:29942558-29943168	H1-hESC	embryonic stem cell:	n/a	chr6:29942794-29942813

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:29942505-29942555	SKMC	muscle:	n/a
2	chr6:29942083-29942133	GM12878	blood:	n/a
3	chr6:29942706-29942756	HMEC	breast:	n/a
4	chr6:29942505-29942555	GM12891	blood:	n/a
5	chr6:29942083-29942133	AG10803	skin:	n/a
6	chr6:29942706-29942756	AG09309	skin:	n/a
7	chr6:29942505-29942555	SAEC	small airway:	n/a
8	chr6:29942083-29942133	ovcar-3	ovarian:	n/a
9	chr6:29942083-29942133	MCF-7	breast:	n/a
10	chr6:29942083-29942133	Caco-2	colon:	n/a
11	chr6:29942083-29942133	SK-N-MC	brain:	n/a
12	chr6:29942706-29942756	HRE	kidney:	n/a
13	chr6:29942706-29942756	Hela-S3	cervix:	n/a
14	chr6:29942706-29942756	CMK	blood:	n/a
15	chr6:29942083-29942133	HL-60	blood:	n/a
16	chr6:29942083-29942133	K562	blood:	n/a
17	chr6:29942083-29942133	HRCEpiC	kidney:	n/a
18	chr6:29942706-29942756	HAEpiC	amniotic membrane:	n/a
19	chr6:29942505-29942555	NT2-D1	testis:	n/a
20	chr6:29942706-29942756	PANC-1	pancreas:	n/a
21	chr6:29942706-29942756	BE2_C	brain:	n/a
22	chr6:29942083-29942133	MCF10A-Er-Src	breast:	n/a
23	chr6:29942706-29942756	HEK293	kidney:	embryo
24	chr6:29942505-29942555	SK-N-SH_RA	brain:	n/a
25	chr6:29942706-29942756	K562	blood:	n/a
26	chr6:29942505-29942555	BE2_C	brain:	n/a
27	chr6:29942505-29942555	AG09319	gingival:	n/a
28	chr6:29942083-29942133	IMR90	lung:	fetal
29	chr6:29942505-29942555	AG10803	skin:	n/a
30	chr6:29942505-29942555	RPTEC	kidney:	n/a
31	chr6:29942083-29942133	HIPEpiC	eye:	n/a
32	chr6:29942083-29942133	ECC-1	luminal epithelium:	n/a
33	chr6:29942505-29942555	NHDF-neo	bronchial:	n/a
34	chr6:29942706-29942756	HCT-116	colon:	n/a
35	chr6:29942706-29942756	GM19239	blood:	n/a
36	chr6:29942706-29942756	ProgFib	skin:	n/a
37	chr6:29942083-29942133	HMEC	breast:	n/a
38	chr6:29942083-29942133	ProgFib	skin:	n/a
39	chr6:29942706-29942756	RPTEC	kidney:	n/a
40	chr6:29942706-29942756	PrEC	prostate:	n/a
41	chr6:29942505-29942555	HNPCEpiC	eye:	n/a
42	chr6:29942505-29942555	GM06990	blood:	n/a
43	chr6:29942706-29942756	HIPEpiC	eye:	n/a
44	chr6:29942706-29942756	H1-hESC	embryonic stem cell:	embryo
45	chr6:29942505-29942555	HRPEpiC	eye:	n/a
46	chr6:29942706-29942756	MCF-7	breast:	n/a
47	chr6:29942505-29942555	HAEpiC	amniotic membrane:	n/a
48	chr6:29942083-29942133	GM12891	blood:	n/a
49	chr6:29942505-29942555	HRE	kidney:	n/a
50	chr6:29942505-29942555	HCPEpiC	choroid plexus:	n/a

No data

Variant related genes	Relation type
HCG9	TF binding region
MICD	TF binding region
HCG9	CpG island
MICD	CpG island

Extended variants
information (count: 45 )
Associated
traits (count: 113 )

Variant overlapped rSNPs/rCNVs (count:45 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2844804	chr6:29942126-29942127	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs35406497	chr6:29942190-29942191	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
3	rs551687588	chr6:29942191-29942192	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
4	rs3823358	chr6:29942205-29942206	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs577248122	chr6:29942206-29942207	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
6	rs367573570	chr6:29942258-29942259	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
7	rs3823359	chr6:29942293-29942294	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs554285212	chr6:29942303-29942304	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs62388722	chr6:29942315-29942316	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs2523945	chr6:29942324-29942325	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
11	rs386698642	chr6:29942384-29942385	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs113540771	chr6:29942392-29942393	Weak transcription Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs370204366	chr6:29942410-29942411	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs116253857	chr6:29942431-29942432	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
15	rs540762842	chr6:29942437-29942438	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs41265816	chr6:29942448-29942449	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
17	rs41265820	chr6:29942449-29942450	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
18	rs376966043	chr6:29942456-29942457	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs532072689	chr6:29942462-29942463	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs453375	chr6:29942487-29942488	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs62388723	chr6:29942489-29942490	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
22	rs554173042	chr6:29942496-29942497	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs393282	chr6:29942497-29942498	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs148741823	chr6:29942506-29942507	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
25	rs143723197	chr6:29942527-29942528	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
26	rs576146699	chr6:29942533-29942534	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
27	rs386698644	chr6:29942539-29942540	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs550832300	chr6:29942541-29942542	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs555229076	chr6:29942570-29942571	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs146841607	chr6:29942575-29942576	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs426483	chr6:29942590-29942591	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Enhancers Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs35066870	chr6:29942639-29942640	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs35159526	chr6:29942673-29942674	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs1960063	chr6:29942674-29942675	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs9260828	chr6:29942678-29942679	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs139910089	chr6:29942697-29942698	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs567777751	chr6:29942706-29942707	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
38	rs200634804	chr6:29942707-29942708	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
39	rs201508068	chr6:29942708-29942709	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
40	rs199648237	chr6:29942710-29942711	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
41	rs531919044	chr6:29942752-29942753	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
42	rs35115129	chr6:29942839-29942840	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs386698645	chr6:29942842-29942843	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs568785057	chr6:29942843-29942844	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs2232238	chr6:29942857-29942858	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:113)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Ewing''s sarcoma	17952124	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Schizophrenia	19571809	CNVD
Schizophrenia	19571808	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
abnormal development	18461090	CNVD
Breast cancer	21509527	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Pancreatic cancer	17952125	CNVD
Rett syndrome	21593744	CNVD

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:29933600-29942400	Weak transcription	Lung	lung
2	chr6:29934400-29944200	Weak transcription	Aorta	Aorta
3	chr6:29934800-29942600	Weak transcription	Brain Substantia Nigra	brain
4	chr6:29935400-29942600	Weak transcription	GM12878-XiMat	blood
5	chr6:29935400-29943400	Weak transcription	Small Intestine	intestine
6	chr6:29935600-29942600	Weak transcription	Brain Anterior Caudate	brain
7	chr6:29935600-29944800	Weak transcription	Dnd41	blood
8	chr6:29935800-29942800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
9	chr6:29936000-29942800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
10	chr6:29936200-29942400	Weak transcription	Right Atrium	heart
11	chr6:29936200-29942400	Weak transcription	Stomach Smooth Muscle	stomach
12	chr6:29936400-29942600	Weak transcription	HepG2	liver
13	chr6:29936400-29943000	Weak transcription	Psoas Muscle	Psoas
14	chr6:29936600-29942200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr6:29936600-29942400	Weak transcription	Skeletal Muscle Male	skeletal muscle
16	chr6:29936600-29942800	Weak transcription	Duodenum Smooth Muscle	Duodenum
17	chr6:29936600-29942800	Weak transcription	HSMMtube	muscle
18	chr6:29936800-29942800	Weak transcription	Sigmoid Colon	Sigmoid Colon
19	chr6:29937200-29942800	Weak transcription	Pancreatic Islets	Pancreatic Islet
20	chr6:29937800-29942800	Weak transcription	K562	blood
21	chr6:29938600-29942800	Weak transcription	Colonic Mucosa	Colon
22	chr6:29939200-29942600	Weak transcription	Adipose Nuclei	Adipose
23	chr6:29940600-29942200	Weak transcription	Right Ventricle	heart
24	chr6:29940600-29942400	Weak transcription	Left Ventricle	heart
25	chr6:29940600-29942400	Weak transcription	Spleen	Spleen
26	chr6:29940600-29942600	Weak transcription	Primary T killer memory cells from peripheral blood	blood
27	chr6:29940800-29942400	Weak transcription	Gastric	stomach
28	chr6:29940800-29942600	Weak transcription	H9 Cell Line	embryonic stem cell
29	chr6:29940800-29942600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
30	chr6:29941600-29944400	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
31	chr6:29941800-29943200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
32	chr6:29942000-29942200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
33	chr6:29942000-29942800	Enhancers	Pancreas	Pancrea
34	chr6:29942200-29942800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr6:29942200-29942800	Enhancers	Right Ventricle	heart
36	chr6:29942200-29943400	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
37	chr6:29942200-29943400	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
38	chr6:29942400-29942600	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
39	chr6:29942400-29942600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr6:29942400-29942600	Flanking Active TSS	Duodenum Mucosa	Duodenum
41	chr6:29942400-29942600	Active TSS	Stomach Smooth Muscle	stomach
42	chr6:29942400-29942800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
43	chr6:29942400-29942800	Enhancers	Left Ventricle	heart
44	chr6:29942400-29942800	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr6:29942400-29942800	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr6:29942400-29943000	Enhancers	Gastric	stomach
47	chr6:29942400-29943000	Enhancers	Lung	lung
48	chr6:29942400-29943000	Enhancers	Right Atrium	heart
49	chr6:29942400-29943000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
50	chr6:29942400-29943600	Bivalent Enhancer	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links